多相脂质体(polyphase lipsomes)是沈阳药学院药剂研究室与上海市长宁区中心医院抗癌药物研究室协作研制。它是抗癌药物载体的多相分散系新剂型。我们研制了“139”等4个品种的多相脂质体,都是把抗癌药物包在一种“导弹”式的载体中,当这种“超微型导弹”静脉注入患者的血液时,能准确地命中靶区(癌组织),对淋巴系统具有定向性,这样就减轻抗癌药对正常细胞的侵 Polyphase lipomes was developed in collaboration with the Pharmacy Research Laboratory of Shenyang Pharmaceutical College and the Research Center of Anti-cancer Drugs, Changning District Central Hospital. It is a new multi-phase dispersion system for anticancer drug carrier. We developed the “139” and other four varieties of multiphasic liposomes, anticancer drugs are packaged in a “missile” type of carrier, when such “micro-missile” intravenous injection of the patient’s blood, Can accurately hit the target area (cancer), the lymphatic system has a directional, thus reducing the anti-cancer drugs on normal cell invasion